annual cash & cash equivalents:
$264.55M+$209.65M(+381.89%)Summary
- As of today (June 22, 2025), CRNX annual cash & cash equivalents is $264.55 million, with the most recent change of +$209.65 million (+381.89%) on December 31, 2024.
- During the last 3 years, CRNX annual cash & cash equivalents has risen by +$63.85 million (+31.81%).
- CRNX annual cash & cash equivalents is now at all-time high.
Performance
CRNX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$94.57M-$169.98M(-64.25%)Summary
- As of today (June 22, 2025), CRNX quarterly cash & cash equivalents is $94.57 million, with the most recent change of -$169.98 million (-64.25%) on March 31, 2025.
- Over the past year, CRNX quarterly cash & cash equivalents has dropped by -$301.36 million (-76.11%).
- CRNX quarterly cash & cash equivalents is now -76.11% below its all-time high of $395.92 million, reached on March 31, 2024.
Performance
CRNX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRNX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +381.9% | -76.1% |
| 3 y3 years | +31.8% | -35.0% |
| 5 y5 years | +556.0% | +85.7% |
CRNX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +709.7% | -76.1% | +205.9% |
| 5 y | 5-year | at high | +709.7% | -76.1% | +205.9% |
| alltime | all time | at high | +2077.0% | -76.1% | +566.4% |
CRNX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $94.57M(-64.3%) |
| Dec 2024 | $264.55M(+381.9%) | $264.55M(-16.6%) |
| Sep 2024 | - | $317.27M(+5.0%) |
| Jun 2024 | - | $302.16M(-23.7%) |
| Mar 2024 | - | $395.92M(+621.2%) |
| Dec 2023 | $54.90M(+68.0%) | $54.90M(-61.6%) |
| Sep 2023 | - | $142.79M(+261.0%) |
| Jun 2023 | - | $39.55M(-4.0%) |
| Mar 2023 | - | $41.19M(+26.1%) |
| Dec 2022 | $32.67M(-83.7%) | $32.67M(+5.7%) |
| Sep 2022 | - | $30.91M(-50.4%) |
| Jun 2022 | - | $62.29M(-57.2%) |
| Mar 2022 | - | $145.55M(-27.5%) |
| Dec 2021 | $200.69M | $200.69M(+24.2%) |
| Sep 2021 | - | $161.54M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $178.77M(+69.3%) |
| Mar 2021 | - | $105.58M(+13.4%) |
| Dec 2020 | $93.09M(+130.8%) | $93.09M(-21.0%) |
| Sep 2020 | - | $117.82M(-26.7%) |
| Jun 2020 | - | $160.81M(+215.8%) |
| Mar 2020 | - | $50.92M(+26.3%) |
| Dec 2019 | $40.33M(-10.3%) | $40.33M(-39.4%) |
| Sep 2019 | - | $66.58M(+11.5%) |
| Jun 2019 | - | $59.72M(-5.0%) |
| Mar 2019 | - | $62.83M(+39.7%) |
| Dec 2018 | $44.97M(+216.9%) | $44.97M(-73.5%) |
| Sep 2018 | - | $169.65M(+148.0%) |
| Jun 2018 | - | $68.41M(-7.2%) |
| Mar 2018 | - | $73.74M(+419.6%) |
| Dec 2017 | $14.19M(+16.8%) | $14.19M |
| Dec 2016 | $12.15M | - |
FAQ
- What is Crinetics Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Crinetics Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Crinetics Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CRNX is $264.55M
What is the all time high annual cash & cash equivalents for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual cash & cash equivalents is $264.55M
What is Crinetics Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CRNX annual cash & cash equivalents has changed by +$209.65M (+381.89%)
What is Crinetics Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CRNX is $94.57M
What is the all time high quarterly cash & cash equivalents for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly cash & cash equivalents is $395.92M
What is Crinetics Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, CRNX quarterly cash & cash equivalents has changed by -$301.36M (-76.11%)